Global Non-Insulin Therapies for Diabetes Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Non-Insulin Therapies for Diabetes Market Size 2017-2028

2.1.2 Non-Insulin Therapies for Diabetes Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Non-Insulin Therapies for Diabetes Segment by Type

2.2.1 Alpha-glucosidase Inhibitors

2.2.2 Amylin Agonists

2.2.3 Biguanides

2.2.4 Dipeptidyl Peptidase-4 (DPP4) Inhibitors

2.2.5 Glinides / Meglitinides

2.2.6 GLP-1 Analogs / GLP-1 Agonists

2.2.7 Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors

2.2.8 Sulfonylureas

2.2.9 Thiazolidinediones

2.2.10 Others

2.3 Non-Insulin Therapies for Diabetes Market Size by Type

2.3.1 Non-Insulin Therapies for Diabetes Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Non-Insulin Therapies for Diabetes Market Size Market Share by Type (2017-2022)

2.4 Non-Insulin Therapies for Diabetes Segment by Application

2.4.1 Monitoring

2.4.2 Diagnosis

2.4.3 Treatment

2.4.4 Others

2.5 Non-Insulin Therapies for Diabetes Market Size by Application

2.5.1 Non-Insulin Therapies for Diabetes Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Non-Insulin Therapies for Diabetes Market Size Market Share by Application (2017-2022)

3 Non-Insulin Therapies for Diabetes Market Size by Player

3.1 Non-Insulin Therapies for Diabetes Market Size Market Share by Players

3.1.1 Global Non-Insulin Therapies for Diabetes Revenue by Players (2020-2022)

3.1.2 Global Non-Insulin Therapies for Diabetes Revenue Market Share by Players (2020-2022)

3.2 Global Non-Insulin Therapies for Diabetes Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Non-Insulin Therapies for Diabetes by Regions

4.1 Non-Insulin Therapies for Diabetes Market Size by Regions (2017-2022)

4.2 Americas Non-Insulin Therapies for Diabetes Market Size Growth (2017-2022)

4.3 APAC Non-Insulin Therapies for Diabetes Market Size Growth (2017-2022)

4.4 Europe Non-Insulin Therapies for Diabetes Market Size Growth (2017-2022)

4.5 Middle East & Africa Non-Insulin Therapies for Diabetes Market Size Growth (2017-2022)

5 Americas

5.1 Americas Non-Insulin Therapies for Diabetes Market Size by Country (2017-2022)

5.2 Americas Non-Insulin Therapies for Diabetes Market Size by Type (2017-2022)

5.3 Americas Non-Insulin Therapies for Diabetes Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Non-Insulin Therapies for Diabetes Market Size by Region (2017-2022)

6.2 APAC Non-Insulin Therapies for Diabetes Market Size by Type (2017-2022)

6.3 APAC Non-Insulin Therapies for Diabetes Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Non-Insulin Therapies for Diabetes by Country (2017-2022)

7.2 Europe Non-Insulin Therapies for Diabetes Market Size by Type (2017-2022)

7.3 Europe Non-Insulin Therapies for Diabetes Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Non-Insulin Therapies for Diabetes by Region (2017-2022)

8.2 Middle East & Africa Non-Insulin Therapies for Diabetes Market Size by Type (2017-2022)

8.3 Middle East & Africa Non-Insulin Therapies for Diabetes Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Non-Insulin Therapies for Diabetes Market Forecast

10.1 Global Non-Insulin Therapies for Diabetes Forecast by Regions (2023-2028)

10.1.1 Global Non-Insulin Therapies for Diabetes Forecast by Regions (2023-2028)

10.1.2 Americas Non-Insulin Therapies for Diabetes Forecast

10.1.3 APAC Non-Insulin Therapies for Diabetes Forecast

10.1.4 Europe Non-Insulin Therapies for Diabetes Forecast

10.1.5 Middle East & Africa Non-Insulin Therapies for Diabetes Forecast

10.2 Americas Non-Insulin Therapies for Diabetes Forecast by Country (2023-2028)

10.2.1 United States Non-Insulin Therapies for Diabetes Market Forecast

10.2.2 Canada Non-Insulin Therapies for Diabetes Market Forecast

10.2.3 Mexico Non-Insulin Therapies for Diabetes Market Forecast

10.2.4 Brazil Non-Insulin Therapies for Diabetes Market Forecast

10.3 APAC Non-Insulin Therapies for Diabetes Forecast by Region (2023-2028)

10.3.1 China Non-Insulin Therapies for Diabetes Market Forecast

10.3.2 Japan Non-Insulin Therapies for Diabetes Market Forecast

10.3.3 Korea Non-Insulin Therapies for Diabetes Market Forecast

10.3.4 Southeast Asia Non-Insulin Therapies for Diabetes Market Forecast

10.3.5 India Non-Insulin Therapies for Diabetes Market Forecast

10.3.6 Australia Non-Insulin Therapies for Diabetes Market Forecast

10.4 Europe Non-Insulin Therapies for Diabetes Forecast by Country (2023-2028)

10.4.1 Germany Non-Insulin Therapies for Diabetes Market Forecast

10.4.2 France Non-Insulin Therapies for Diabetes Market Forecast

10.4.3 UK Non-Insulin Therapies for Diabetes Market Forecast

10.4.4 Italy Non-Insulin Therapies for Diabetes Market Forecast

10.4.5 Russia Non-Insulin Therapies for Diabetes Market Forecast

10.5 Middle East & Africa Non-Insulin Therapies for Diabetes Forecast by Region (2023-2028)

10.5.1 Egypt Non-Insulin Therapies for Diabetes Market Forecast

10.5.2 South Africa Non-Insulin Therapies for Diabetes Market Forecast

10.5.3 Israel Non-Insulin Therapies for Diabetes Market Forecast

10.5.4 Turkey Non-Insulin Therapies for Diabetes Market Forecast

10.5.5 GCC Countries Non-Insulin Therapies for Diabetes Market Forecast

10.6 Global Non-Insulin Therapies for Diabetes Forecast by Type (2023-2028)

10.7 Global Non-Insulin Therapies for Diabetes Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 GSK

11.1.1 GSK Company Information

11.1.2 GSK Non-Insulin Therapies for Diabetes Product Offered

11.1.3 GSK Non-Insulin Therapies for Diabetes Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 GSK Main Business Overview

11.1.5 GSK Latest Developments

11.2 Eli Lilly

11.2.1 Eli Lilly Company Information

11.2.2 Eli Lilly Non-Insulin Therapies for Diabetes Product Offered

11.2.3 Eli Lilly Non-Insulin Therapies for Diabetes Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Eli Lilly Main Business Overview

11.2.5 Eli Lilly Latest Developments

11.3 Sumitomo Dainippon Pharma

11.3.1 Sumitomo Dainippon Pharma Company Information

11.3.2 Sumitomo Dainippon Pharma Non-Insulin Therapies for Diabetes Product Offered

11.3.3 Sumitomo Dainippon Pharma Non-Insulin Therapies for Diabetes Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Sumitomo Dainippon Pharma Main Business Overview

11.3.5 Sumitomo Dainippon Pharma Latest Developments

11.4 Intarcia Therapeutics

11.4.1 Intarcia Therapeutics Company Information

11.4.2 Intarcia Therapeutics Non-Insulin Therapies for Diabetes Product Offered

11.4.3 Intarcia Therapeutics Non-Insulin Therapies for Diabetes Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Intarcia Therapeutics Main Business Overview

11.4.5 Intarcia Therapeutics Latest Developments

11.5 Servier

11.5.1 Servier Company Information

11.5.2 Servier Non-Insulin Therapies for Diabetes Product Offered

11.5.3 Servier Non-Insulin Therapies for Diabetes Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Servier Main Business Overview

11.5.5 Servier Latest Developments

11.6 Pfizer

11.6.1 Pfizer Company Information

11.6.2 Pfizer Non-Insulin Therapies for Diabetes Product Offered

11.6.3 Pfizer Non-Insulin Therapies for Diabetes Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Pfizer Main Business Overview

11.6.5 Pfizer Latest Developments

11.7 Merck

11.7.1 Merck Company Information

11.7.2 Merck Non-Insulin Therapies for Diabetes Product Offered

11.7.3 Merck Non-Insulin Therapies for Diabetes Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Merck Main Business Overview

11.7.5 Merck Latest Developments

11.8 Dong-A Pharmaceutical

11.8.1 Dong-A Pharmaceutical Company Information

11.8.2 Dong-A Pharmaceutical Non-Insulin Therapies for Diabetes Product Offered

11.8.3 Dong-A Pharmaceutical Non-Insulin Therapies for Diabetes Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Dong-A Pharmaceutical Main Business Overview

11.8.5 Dong-A Pharmaceutical Latest Developments

11.9 Luye Pharma Group

11.9.1 Luye Pharma Group Company Information

11.9.2 Luye Pharma Group Non-Insulin Therapies for Diabetes Product Offered

11.9.3 Luye Pharma Group Non-Insulin Therapies for Diabetes Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Luye Pharma Group Main Business Overview

11.9.5 Luye Pharma Group Latest Developments

11.10 Eurofarma

11.10.1 Eurofarma Company Information

11.10.2 Eurofarma Non-Insulin Therapies for Diabetes Product Offered

11.10.3 Eurofarma Non-Insulin Therapies for Diabetes Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Eurofarma Main Business Overview

11.10.5 Eurofarma Latest Developments

11.11 Geropharm

11.11.1 Geropharm Company Information

11.11.2 Geropharm Non-Insulin Therapies for Diabetes Product Offered

11.11.3 Geropharm Non-Insulin Therapies for Diabetes Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Geropharm Main Business Overview

11.11.5 Geropharm Latest Developments

11.12 Alkem Labs

11.12.1 Alkem Labs Company Information

11.12.2 Alkem Labs Non-Insulin Therapies for Diabetes Product Offered

11.12.3 Alkem Labs Non-Insulin Therapies for Diabetes Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Alkem Labs Main Business Overview

11.12.5 Alkem Labs Latest Developments

11.13 SatRx

11.13.1 SatRx Company Information

11.13.2 SatRx Non-Insulin Therapies for Diabetes Product Offered

11.13.3 SatRx Non-Insulin Therapies for Diabetes Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 SatRx Main Business Overview

11.13.5 SatRx Latest Developments

11.14 Jiangsu Hansoh Pharmaceutical

11.14.1 Jiangsu Hansoh Pharmaceutical Company Information

11.14.2 Jiangsu Hansoh Pharmaceutical Non-Insulin Therapies for Diabetes Product Offered

11.14.3 Jiangsu Hansoh Pharmaceutical Non-Insulin Therapies for Diabetes Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 Jiangsu Hansoh Pharmaceutical Main Business Overview

11.14.5 Jiangsu Hansoh Pharmaceutical Latest Developments

11.15 Novo Nordisk

11.15.1 Novo Nordisk Company Information

11.15.2 Novo Nordisk Non-Insulin Therapies for Diabetes Product Offered

11.15.3 Novo Nordisk Non-Insulin Therapies for Diabetes Revenue, Gross Margin and Market Share (2020-2022)

11.15.4 Novo Nordisk Main Business Overview

11.15.5 Novo Nordisk Latest Developments

11.16 Emisphere

11.16.1 Emisphere Company Information

11.16.2 Emisphere Non-Insulin Therapies for Diabetes Product Offered

11.16.3 Emisphere Non-Insulin Therapies for Diabetes Revenue, Gross Margin and Market Share (2020-2022)

11.16.4 Emisphere Main Business Overview

11.16.5 Emisphere Latest Developments

11.17 Uni-Bio Science Group

11.17.1 Uni-Bio Science Group Company Information

11.17.2 Uni-Bio Science Group Non-Insulin Therapies for Diabetes Product Offered

11.17.3 Uni-Bio Science Group Non-Insulin Therapies for Diabetes Revenue, Gross Margin and Market Share (2020-2022)

11.17.4 Uni-Bio Science Group Main Business Overview

11.17.5 Uni-Bio Science Group Latest Developments

11.18 Takeda

11.18.1 Takeda Company Information

11.18.2 Takeda Non-Insulin Therapies for Diabetes Product Offered

11.18.3 Takeda Non-Insulin Therapies for Diabetes Revenue, Gross Margin and Market Share (2020-2022)

11.18.4 Takeda Main Business Overview

11.18.5 Takeda Latest Developments

11.19 3SBio

11.19.1 3SBio Company Information

11.19.2 3SBio Non-Insulin Therapies for Diabetes Product Offered

11.19.3 3SBio Non-Insulin Therapies for Diabetes Revenue, Gross Margin and Market Share (2020-2022)

11.19.4 3SBio Main Business Overview

11.19.5 3SBio Latest Developments

11.20 Jiangsu Hengrui Medicine

11.20.1 Jiangsu Hengrui Medicine Company Information

11.20.2 Jiangsu Hengrui Medicine Non-Insulin Therapies for Diabetes Product Offered

11.20.3 Jiangsu Hengrui Medicine Non-Insulin Therapies for Diabetes Revenue, Gross Margin and Market Share (2020-2022)

11.20.4 Jiangsu Hengrui Medicine Main Business Overview

11.20.5 Jiangsu Hengrui Medicine Latest Developments

12 Research Findings and Conclusion

Table 1. Non-Insulin Therapies for Diabetes Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Alpha-glucosidase Inhibitors

Table 3. Major Players of Amylin Agonists

Table 4. Major Players of Biguanides

Table 5. Major Players of Dipeptidyl Peptidase-4 (DPP4) Inhibitors

Table 6. Major Players of Glinides / Meglitinides

Table 7. Major Players of GLP-1 Analogs / GLP-1 Agonists

Table 8. Major Players of Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors

Table 9. Major Players of Sulfonylureas

Table 10. Major Players of Thiazolidinediones

Table 11. Major Players of Others

Table 12. Non-Insulin Therapies for Diabetes Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 13. Global Non-Insulin Therapies for Diabetes Market Size by Type (2017-2022) & ($ Millions)

Table 14. Global Non-Insulin Therapies for Diabetes Market Size Market Share by Type (2017-2022)

Table 15. Non-Insulin Therapies for Diabetes Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 16. Global Non-Insulin Therapies for Diabetes Market Size by Application (2017-2022) & ($ Millions)

Table 17. Global Non-Insulin Therapies for Diabetes Market Size Market Share by Application (2017-2022)

Table 18. Global Non-Insulin Therapies for Diabetes Revenue by Players (2020-2022) & ($ Millions)

Table 19. Global Non-Insulin Therapies for Diabetes Revenue Market Share by Player (2020-2022)

Table 20. Non-Insulin Therapies for Diabetes Key Players Head office and Products Offered

Table 21. Non-Insulin Therapies for Diabetes Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 22. New Products and Potential Entrants

Table 23. Mergers & Acquisitions, Expansion

Table 24. Global Non-Insulin Therapies for Diabetes Market Size by Regions 2017-2022 & ($ Millions)

Table 25. Global Non-Insulin Therapies for Diabetes Market Size Market Share by Regions (2017-2022)

Table 26. Americas Non-Insulin Therapies for Diabetes Market Size by Country (2017-2022) & ($ Millions)

Table 27. Americas Non-Insulin Therapies for Diabetes Market Size Market Share by Country (2017-2022)

Table 28. Americas Non-Insulin Therapies for Diabetes Market Size by Type (2017-2022) & ($ Millions)

Table 29. Americas Non-Insulin Therapies for Diabetes Market Size Market Share by Type (2017-2022)

Table 30. Americas Non-Insulin Therapies for Diabetes Market Size by Application (2017-2022) & ($ Millions)

Table 31. Americas Non-Insulin Therapies for Diabetes Market Size Market Share by Application (2017-2022)

Table 32. APAC Non-Insulin Therapies for Diabetes Market Size by Region (2017-2022) & ($ Millions)

Table 33. APAC Non-Insulin Therapies for Diabetes Market Size Market Share by Region (2017-2022)

Table 34. APAC Non-Insulin Therapies for Diabetes Market Size by Type (2017-2022) & ($ Millions)

Table 35. APAC Non-Insulin Therapies for Diabetes Market Size Market Share by Type (2017-2022)

Table 36. APAC Non-Insulin Therapies for Diabetes Market Size by Application (2017-2022) & ($ Millions)

Table 37. APAC Non-Insulin Therapies for Diabetes Market Size Market Share by Application (2017-2022)

Table 38. Europe Non-Insulin Therapies for Diabetes Market Size by Country (2017-2022) & ($ Millions)

Table 39. Europe Non-Insulin Therapies for Diabetes Market Size Market Share by Country (2017-2022)

Table 40. Europe Non-Insulin Therapies for Diabetes Market Size by Type (2017-2022) & ($ Millions)

Table 41. Europe Non-Insulin Therapies for Diabetes Market Size Market Share by Type (2017-2022)

Table 42. Europe Non-Insulin Therapies for Diabetes Market Size by Application (2017-2022) & ($ Millions)

Table 43. Europe Non-Insulin Therapies for Diabetes Market Size Market Share by Application (2017-2022)

Table 44. Middle East & Africa Non-Insulin Therapies for Diabetes Market Size by Region (2017-2022) & ($ Millions)

Table 45. Middle East & Africa Non-Insulin Therapies for Diabetes Market Size Market Share by Region (2017-2022)

Table 46. Middle East & Africa Non-Insulin Therapies for Diabetes Market Size by Type (2017-2022) & ($ Millions)

Table 47. Middle East & Africa Non-Insulin Therapies for Diabetes Market Size Market Share by Type (2017-2022)

Table 48. Middle East & Africa Non-Insulin Therapies for Diabetes Market Size by Application (2017-2022) & ($ Millions)

Table 49. Middle East & Africa Non-Insulin Therapies for Diabetes Market Size Market Share by Application (2017-2022)

Table 50. Key Market Drivers & Growth Opportunities of Non-Insulin Therapies for Diabetes

Table 51. Key Market Challenges & Risks of Non-Insulin Therapies for Diabetes

Table 52. Key Industry Trends of Non-Insulin Therapies for Diabetes

Table 53. Global Non-Insulin Therapies for Diabetes Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 54. Global Non-Insulin Therapies for Diabetes Market Size Market Share Forecast by Regions (2023-2028)

Table 55. Global Non-Insulin Therapies for Diabetes Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 56. Global Non-Insulin Therapies for Diabetes Market Size Market Share Forecast by Type (2023-2028)

Table 57. Global Non-Insulin Therapies for Diabetes Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 58. Global Non-Insulin Therapies for Diabetes Market Size Market Share Forecast by Application (2023-2028)

Table 59. GSK Details, Company Type, Non-Insulin Therapies for Diabetes Area Served and Its Competitors

Table 60. GSK Non-Insulin Therapies for Diabetes Product Offered

Table 61. GSK Non-Insulin Therapies for Diabetes Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 62. GSK Main Business

Table 63. GSK Latest Developments

Table 64. Eli Lilly Details, Company Type, Non-Insulin Therapies for Diabetes Area Served and Its Competitors

Table 65. Eli Lilly Non-Insulin Therapies for Diabetes Product Offered

Table 66. Eli Lilly Main Business

Table 67. Eli Lilly Non-Insulin Therapies for Diabetes Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 68. Eli Lilly Latest Developments

Table 69. Sumitomo Dainippon Pharma Details, Company Type, Non-Insulin Therapies for Diabetes Area Served and Its Competitors

Table 70. Sumitomo Dainippon Pharma Non-Insulin Therapies for Diabetes Product Offered

Table 71. Sumitomo Dainippon Pharma Main Business

Table 72. Sumitomo Dainippon Pharma Non-Insulin Therapies for Diabetes Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 73. Sumitomo Dainippon Pharma Latest Developments

Table 74. Intarcia Therapeutics Details, Company Type, Non-Insulin Therapies for Diabetes Area Served and Its Competitors

Table 75. Intarcia Therapeutics Non-Insulin Therapies for Diabetes Product Offered

Table 76. Intarcia Therapeutics Main Business

Table 77. Intarcia Therapeutics Non-Insulin Therapies for Diabetes Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 78. Intarcia Therapeutics Latest Developments

Table 79. Servier Details, Company Type, Non-Insulin Therapies for Diabetes Area Served and Its Competitors

Table 80. Servier Non-Insulin Therapies for Diabetes Product Offered

Table 81. Servier Main Business

Table 82. Servier Non-Insulin Therapies for Diabetes Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 83. Servier Latest Developments

Table 84. Pfizer Details, Company Type, Non-Insulin Therapies for Diabetes Area Served and Its Competitors

Table 85. Pfizer Non-Insulin Therapies for Diabetes Product Offered

Table 86. Pfizer Main Business

Table 87. Pfizer Non-Insulin Therapies for Diabetes Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 88. Pfizer Latest Developments

Table 89. Merck Details, Company Type, Non-Insulin Therapies for Diabetes Area Served and Its Competitors

Table 90. Merck Non-Insulin Therapies for Diabetes Product Offered

Table 91. Merck Main Business

Table 92. Merck Non-Insulin Therapies for Diabetes Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 93. Merck Latest Developments

Table 94. Dong-A Pharmaceutical Details, Company Type, Non-Insulin Therapies for Diabetes Area Served and Its Competitors

Table 95. Dong-A Pharmaceutical Non-Insulin Therapies for Diabetes Product Offered

Table 96. Dong-A Pharmaceutical Main Business

Table 97. Dong-A Pharmaceutical Non-Insulin Therapies for Diabetes Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 98. Dong-A Pharmaceutical Latest Developments

Table 99. Luye Pharma Group Details, Company Type, Non-Insulin Therapies for Diabetes Area Served and Its Competitors

Table 100. Luye Pharma Group Non-Insulin Therapies for Diabetes Product Offered

Table 101. Luye Pharma Group Main Business

Table 102. Luye Pharma Group Non-Insulin Therapies for Diabetes Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 103. Luye Pharma Group Latest Developments

Table 104. Eurofarma Details, Company Type, Non-Insulin Therapies for Diabetes Area Served and Its Competitors

Table 105. Eurofarma Non-Insulin Therapies for Diabetes Product Offered

Table 106. Eurofarma Main Business

Table 107. Eurofarma Non-Insulin Therapies for Diabetes Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 108. Eurofarma Latest Developments

Table 109. Geropharm Details, Company Type, Non-Insulin Therapies for Diabetes Area Served and Its Competitors

Table 110. Geropharm Non-Insulin Therapies for Diabetes Product Offered

Table 111. Geropharm Non-Insulin Therapies for Diabetes Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 112. Geropharm Main Business

Table 113. Geropharm Latest Developments

Table 114. Alkem Labs Details, Company Type, Non-Insulin Therapies for Diabetes Area Served and Its Competitors

Table 115. Alkem Labs Non-Insulin Therapies for Diabetes Product Offered

Table 116. Alkem Labs Main Business

Table 117. Alkem Labs Non-Insulin Therapies for Diabetes Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 118. Alkem Labs Latest Developments

Table 119. SatRx Details, Company Type, Non-Insulin Therapies for Diabetes Area Served and Its Competitors

Table 120. SatRx Non-Insulin Therapies for Diabetes Product Offered

Table 121. SatRx Main Business

Table 122. SatRx Non-Insulin Therapies for Diabetes Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 123. SatRx Latest Developments

Table 124. Jiangsu Hansoh Pharmaceutical Details, Company Type, Non-Insulin Therapies for Diabetes Area Served and Its Competitors

Table 125. Jiangsu Hansoh Pharmaceutical Non-Insulin Therapies for Diabetes Product Offered

Table 126. Jiangsu Hansoh Pharmaceutical Main Business

Table 127. Jiangsu Hansoh Pharmaceutical Non-Insulin Therapies for Diabetes Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 128. Jiangsu Hansoh Pharmaceutical Latest Developments

Table 129. Novo Nordisk Details, Company Type, Non-Insulin Therapies for Diabetes Area Served and Its Competitors

Table 130. Novo Nordisk Non-Insulin Therapies for Diabetes Product Offered

Table 131. Novo Nordisk Main Business

Table 132. Novo Nordisk Non-Insulin Therapies for Diabetes Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 133. Novo Nordisk Latest Developments

Table 134. Emisphere Details, Company Type, Non-Insulin Therapies for Diabetes Area Served and Its Competitors

Table 135. Emisphere Non-Insulin Therapies for Diabetes Product Offered

Table 136. Emisphere Main Business

Table 137. Emisphere Non-Insulin Therapies for Diabetes Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 138. Emisphere Latest Developments

Table 139. Uni-Bio Science Group Details, Company Type, Non-Insulin Therapies for Diabetes Area Served and Its Competitors

Table 140. Uni-Bio Science Group Non-Insulin Therapies for Diabetes Product Offered

Table 141. Uni-Bio Science Group Main Business

Table 142. Uni-Bio Science Group Non-Insulin Therapies for Diabetes Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 143. Uni-Bio Science Group Latest Developments

Table 144. Takeda Details, Company Type, Non-Insulin Therapies for Diabetes Area Served and Its Competitors

Table 145. Takeda Non-Insulin Therapies for Diabetes Product Offered

Table 146. Takeda Main Business

Table 147. Takeda Non-Insulin Therapies for Diabetes Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 148. Takeda Latest Developments

Table 149. 3SBio Details, Company Type, Non-Insulin Therapies for Diabetes Area Served and Its Competitors

Table 150. 3SBio Non-Insulin Therapies for Diabetes Product Offered

Table 151. 3SBio Main Business

Table 152. 3SBio Non-Insulin Therapies for Diabetes Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 153. 3SBio Latest Developments

Table 154. Jiangsu Hengrui Medicine Details, Company Type, Non-Insulin Therapies for Diabetes Area Served and Its Competitors

Table 155. Jiangsu Hengrui Medicine Non-Insulin Therapies for Diabetes Product Offered

Table 156. Jiangsu Hengrui Medicine Main Business

Table 157. Jiangsu Hengrui Medicine Non-Insulin Therapies for Diabetes Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 158. Jiangsu Hengrui Medicine Latest Developments

List of Figures

Figure 1. Non-Insulin Therapies for Diabetes Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Non-Insulin Therapies for Diabetes Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Non-Insulin Therapies for Diabetes Market Size Market Share by Type in 2021

Figure 7. Non-Insulin Therapies for Diabetes in Monitoring

Figure 8. Global Non-Insulin Therapies for Diabetes Market: Monitoring (2017-2022) & ($ Millions)

Figure 9. Non-Insulin Therapies for Diabetes in Diagnosis

Figure 10. Global Non-Insulin Therapies for Diabetes Market: Diagnosis (2017-2022) & ($ Millions)

Figure 11. Non-Insulin Therapies for Diabetes in Treatment

Figure 12. Global Non-Insulin Therapies for Diabetes Market: Treatment (2017-2022) & ($ Millions)

Figure 13. Non-Insulin Therapies for Diabetes in Others

Figure 14. Global Non-Insulin Therapies for Diabetes Market: Others (2017-2022) & ($ Millions)

Figure 15. Global Non-Insulin Therapies for Diabetes Market Size Market Share by Application in 2021

Figure 16. Global Non-Insulin Therapies for Diabetes Revenue Market Share by Player in 2021

Figure 17. Global Non-Insulin Therapies for Diabetes Market Size Market Share by Regions (2017-2022)

Figure 18. Americas Non-Insulin Therapies for Diabetes Market Size 2017-2022 ($ Millions)

Figure 19. APAC Non-Insulin Therapies for Diabetes Market Size 2017-2022 ($ Millions)

Figure 20. Europe Non-Insulin Therapies for Diabetes Market Size 2017-2022 ($ Millions)

Figure 21. Middle East & Africa Non-Insulin Therapies for Diabetes Market Size 2017-2022 ($ Millions)

Figure 22. Americas Non-Insulin Therapies for Diabetes Value Market Share by Country in 2021

Figure 23. Americas Non-Insulin Therapies for Diabetes Consumption Market Share by Type in 2021

Figure 24. Americas Non-Insulin Therapies for Diabetes Market Size Market Share by Application in 2021

Figure 25. United States Non-Insulin Therapies for Diabetes Market Size Growth 2017-2022 ($ Millions)

Figure 26. Canada Non-Insulin Therapies for Diabetes Market Size Growth 2017-2022 ($ Millions)

Figure 27. Mexico Non-Insulin Therapies for Diabetes Market Size Growth 2017-2022 ($ Millions)

Figure 28. Brazil Non-Insulin Therapies for Diabetes Market Size Growth 2017-2022 ($ Millions)

Figure 29. APAC Non-Insulin Therapies for Diabetes Market Size Market Share by Region in 2021

Figure 30. APAC Non-Insulin Therapies for Diabetes Market Size Market Share by Application in 2021

Figure 31. China Non-Insulin Therapies for Diabetes Market Size Growth 2017-2022 ($ Millions)

Figure 32. Japan Non-Insulin Therapies for Diabetes Market Size Growth 2017-2022 ($ Millions)

Figure 33. Korea Non-Insulin Therapies for Diabetes Market Size Growth 2017-2022 ($ Millions)

Figure 34. Southeast Asia Non-Insulin Therapies for Diabetes Market Size Growth 2017-2022 ($ Millions)

Figure 35. India Non-Insulin Therapies for Diabetes Market Size Growth 2017-2022 ($ Millions)

Figure 36. Australia Non-Insulin Therapies for Diabetes Market Size Growth 2017-2022 ($ Millions)

Figure 37. Europe Non-Insulin Therapies for Diabetes Market Size Market Share by Country in 2021

Figure 38. Europe Non-Insulin Therapies for Diabetes Market Size Market Share by Type in 2021

Figure 39. Europe Non-Insulin Therapies for Diabetes Market Size Market Share by Application in 2021

Figure 40. Germany Non-Insulin Therapies for Diabetes Market Size Growth 2017-2022 ($ Millions)

Figure 41. France Non-Insulin Therapies for Diabetes Market Size Growth 2017-2022 ($ Millions)

Figure 42. UK Non-Insulin Therapies for Diabetes Market Size Growth 2017-2022 ($ Millions)

Figure 43. Italy Non-Insulin Therapies for Diabetes Market Size Growth 2017-2022 ($ Millions)

Figure 44. Russia Non-Insulin Therapies for Diabetes Market Size Growth 2017-2022 ($ Millions)

Figure 45. Middle East & Africa Non-Insulin Therapies for Diabetes Market Size Market Share by Region in 2021

Figure 46. Middle East & Africa Non-Insulin Therapies for Diabetes Market Size Market Share by Type in 2021

Figure 47. Middle East & Africa Non-Insulin Therapies for Diabetes Market Size Market Share by Application in 2021

Figure 48. Egypt Non-Insulin Therapies for Diabetes Market Size Growth 2017-2022 ($ Millions)

Figure 49. South Africa Non-Insulin Therapies for Diabetes Market Size Growth 2017-2022 ($ Millions)

Figure 50. Israel Non-Insulin Therapies for Diabetes Market Size Growth 2017-2022 ($ Millions)

Figure 51. Turkey Non-Insulin Therapies for Diabetes Market Size Growth 2017-2022 ($ Millions)

Figure 52. GCC Country Non-Insulin Therapies for Diabetes Market Size Growth 2017-2022 ($ Millions)

Figure 53. Americas Non-Insulin Therapies for Diabetes Market Size 2023-2028 ($ Millions)

Figure 54. APAC Non-Insulin Therapies for Diabetes Market Size 2023-2028 ($ Millions)

Figure 55. Europe Non-Insulin Therapies for Diabetes Market Size 2023-2028 ($ Millions)

Figure 56. Middle East & Africa Non-Insulin Therapies for Diabetes Market Size 2023-2028 ($ Millions)

Figure 57. United States Non-Insulin Therapies for Diabetes Market Size 2023-2028 ($ Millions)

Figure 58. Canada Non-Insulin Therapies for Diabetes Market Size 2023-2028 ($ Millions)

Figure 59. Mexico Non-Insulin Therapies for Diabetes Market Size 2023-2028 ($ Millions)

Figure 60. Brazil Non-Insulin Therapies for Diabetes Market Size 2023-2028 ($ Millions)

Figure 61. China Non-Insulin Therapies for Diabetes Market Size 2023-2028 ($ Millions)

Figure 62. Japan Non-Insulin Therapies for Diabetes Market Size 2023-2028 ($ Millions)

Figure 63. Korea Non-Insulin Therapies for Diabetes Market Size 2023-2028 ($ Millions)

Figure 64. Southeast Asia Non-Insulin Therapies for Diabetes Market Size 2023-2028 ($ Millions)

Figure 65. India Non-Insulin Therapies for Diabetes Market Size 2023-2028 ($ Millions)

Figure 66. Australia Non-Insulin Therapies for Diabetes Market Size 2023-2028 ($ Millions)

Figure 67. Germany Non-Insulin Therapies for Diabetes Market Size 2023-2028 ($ Millions)

Figure 68. France Non-Insulin Therapies for Diabetes Market Size 2023-2028 ($ Millions)

Figure 69. UK Non-Insulin Therapies for Diabetes Market Size 2023-2028 ($ Millions)

Figure 70. Italy Non-Insulin Therapies for Diabetes Market Size 2023-2028 ($ Millions)

Figure 71. Russia Non-Insulin Therapies for Diabetes Market Size 2023-2028 ($ Millions)

Figure 72. Spain Non-Insulin Therapies for Diabetes Market Size 2023-2028 ($ Millions)

Figure 73. Egypt Non-Insulin Therapies for Diabetes Market Size 2023-2028 ($ Millions)

Figure 74. South Africa Non-Insulin Therapies for Diabetes Market Size 2023-2028 ($ Millions)

Figure 75. Israel Non-Insulin Therapies for Diabetes Market Size 2023-2028 ($ Millions)

Figure 76. Turkey Non-Insulin Therapies for Diabetes Market Size 2023-2028 ($ Millions)

Figure 77. GCC Countries Non-Insulin Therapies for Diabetes Market Size 2023-2028 ($ Millions)